BURLINGTON, Mass., Aug. 9, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 14, 2023.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:Sara SilvermanHead of Investor Relations & Corporate Communicationsir@azenta.com
Sherry Dinsmoresherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-8th-annual-needham-virtual-medtech--diagnostics-1x1-conference-301897222.html
SOURCE Azenta